Enfiera Injection: Uses, Strengths, Composition and Safety Information

Enfiera Injection is a prescription medicine containing rituximab, a monoclonal antibody used to treat certain blood cancers and autoimmune conditions. It works by targeting specific B cells involved in these diseases. In India, Enfiera Injection is available in different strengths, including 100 mg and 500 mg presentations. The appropriate formulation and treatment schedule depend on the patient's diagnosis and the treating specialist's advice.

Enfiera Injection – Product Description

Enfiera Injection contains rituximab, a targeted biological medicine that binds to the CD20 protein on certain B lymphocytes, a type of white blood cell. By reducing these cells, rituximab can help control particular malignant and immune-mediated conditions.

Doctors may prescribe Enfiera for eligible patients with non-Hodgkin lymphoma, chronic lymphocytic leukaemia, rheumatoid arthritis, granulomatosis with polyangiitis, or microscopic polyangiitis, depending on the approved indication and individual clinical circumstances.

This medicine is administered by intravenous infusion in a healthcare setting under appropriate medical supervision. It is not intended for self-administration.

Enfiera Injection Strengths and Presentations

Enfiera Injection is listed in the Indian market in the following strengths:

Enfiera 100 mg Injection: A 100 mg rituximab presentation, commonly supplied in a 10 mL vial.

Enfiera 500 mg Injection: A 500 mg rituximab presentation, commonly supplied in a 50 mL vial.

Availability, pack size, manufacturer and product labelling may vary. Always verify the vial label, package insert, batch details and current product information before procurement or administration.

Uses and Potential Clinical Benefits of Enfiera

Enfiera may be prescribed for specific conditions, including:

Non-Hodgkin lymphoma: Used in selected treatment regimens for certain types of lymphoma.

Chronic lymphocytic leukaemia (CLL): May be used as part of a specialist-directed treatment plan.

Rheumatoid arthritis: Can help control disease activity in eligible patients when clinically appropriate.

Granulomatosis with polyangiitis: Used in selected cases of this inflammatory blood vessel disease.

Microscopic polyangiitis: May help manage this autoimmune condition under specialist care.

Treatment outcomes depend on the condition, disease severity, combination therapy and individual response. Enfiera is not suitable for every patient with these conditions, and its benefits and risks must be assessed by a qualified doctor.

Important Safety Information and Storage

Rituximab can cause infusion-related reactions, infections and other potentially serious adverse effects. Other possible effects include fever, chills, nausea, fatigue and headache. Rare but serious complications can occur.

Before treatment, patients should inform their doctor about current or previous infections, hepatitis B, other medical conditions, vaccinations and all medicines they use. The healthcare team may recommend screening and monitoring before, during and after treatment.

Enfiera is generally stored under refrigerated conditions at 2–8°C and must not be frozen. Follow the specific product label and approved handling instructions. Cold-chain handling is essential to help maintain product quality.

Prescription notice: Enfiera Injection should be used only on a specialist's prescription and administered by trained healthcare professionals. Never change the dose or treatment schedule without medical advice.

Frequently Asked Questions About Enfiera Injection

1. What is Enfiera Injection used for?

Enfiera contains rituximab and is prescribed for certain blood cancers and autoimmune disorders, depending on the approved indication and the patient's clinical condition.

2. What strengths of Enfiera Injection are available?

Commonly listed presentations include Enfiera 100 mg and Enfiera 500 mg. Confirm current availability and pack details with a licensed pharmaceutical supplier.

3. Is Enfiera Injection a chemotherapy medicine?

Rituximab is a targeted monoclonal antibody, not a conventional cytotoxic chemotherapy drug. However, it may be combined with chemotherapy in certain cancer treatment regimens.

4. Can Enfiera Injection be administered at home?

No. It requires intravenous administration and appropriate monitoring by trained healthcare professionals because infusion reactions and serious adverse effects are possible.

5. How should Enfiera Injection be stored?

Follow the approved product instructions. Rituximab injections generally require refrigeration at 2–8°C and must not be frozen.

6. Can Enfiera Injection be purchased online in India?

Availability depends on the licensed seller, prescription requirements and applicable Indian regulations. Verify the supplier's credentials, product authenticity and cold-chain arrangements before purchase.